Recovery Rheum

04/22/2026

A lawsuit between a major pharmaceutical company and the U.S. Food and Drug Administration could quietly reshape your access to medications for decades.

The fight?

Whether certain peptide drugs should be classified as biologics instead of drugs.

Why push for that?

Because biologics come with:

⚠️ Longer exclusivity

⚠️ Fewer competitors

⚠️ Higher barriers to generics

In other words — more control over the market.

And here’s the part most people miss:

That decision can come down to subtle molecular structure differences.

If this argument wins, it won’t just affect one drug…

It could change how an entire generation of therapies is priced, protected, and accessed.

04/19/2026

Current evidence does not demonstrate a definitive causal link between commonly discussed peptides and cancer in vitro or in vivo. However, more long-term human studies are needed to fully understand safety. Educational only. Not medical advice.

04/17/2026

Gout is associated with systemic inflammation and has been linked in some studies to increased cardiovascular risk following flares. Proper management is important for overall health.

04/16/2026

Peptides are an emerging area of research that may play a future role in how we approach autoimmune disease and chronic inflammation. Compounds like BPC-157 and Thymosin Beta-4 are being studied for their potential effects on tissue repair and healing, while Thymosin Alpha-1 has been explored for its role in immune system signaling and balance. Growth hormone–related peptides like CJC-1295 with Ipamorelin may also influence recovery and metabolic pathways that intersect with inflammation. While this science is still evolving, the goal is the same: to better understand how we can support the body’s natural repair and regulatory systems in a more targeted way.

04/11/2026

A new study from Eli Lilly and Company suggests a powerful new way to treat psoriatic arthritis by combining inflammation control with metabolic therapy. Patients treated with both Taltz and Zepbound had significantly better outcomes than those on biologic therapy alone—including higher arthritis response rates and meaningful weight loss. In fact, about one-third of patients on the combination achieved major improvement in joint disease plus ≥10% weight loss, compared to almost none on Taltz alone. These findings highlight a growing concept in medicine: targeting both immune inflammation and metabolic pathways together may lead to better results in complex diseases like psoriatic arthritis.

04/10/2026

An unhealthy gut microbiome can make it harder for your body to benefit from supplements. The trillions of bacteria in your gut help break down nutrients, support absorption, and even activate certain compounds so your body can use them. When the microbiome is out of balance, the gut lining can become irritated or “leaky,” and helpful bacteria may be reduced. This can lead to poor absorption, meaning that even high-quality supplements may not be fully utilized. In other words, if the gut isn’t functioning well, your body may not be able to access the benefits of what you’re taking.

04/05/2026

Chronic inflammation has been associated with processes involved in aging and cellular function. Addressing inflammation may play a role in overall health.

03/27/2026

03/19/2026

Autoimmune fatigue isn’t just “being tired” — it’s a biologic response driven by inflammation. Cytokines like TNF-alpha, IL-1, and IL-6 signal the brain to create “sickness behavior,” while also impairing mitochondria and reducing cellular energy (ATP). Add in autonomic dysfunction affecting blood flow, and it’s no wonder even small tasks feel overwhelming. This is why autoimmune fatigue feels so different — and why understanding the underlying physiology is key to better treatment.

03/14/2026

Autoimmune diseases rarely travel alone. Patients with conditions like rheumatoid arthritis, lupus, thyroid disease, or Sjögren’s often develop more than one autoimmune condition over time—a pattern called polyautoimmunity. Genetics such as certain HLA immune genes, infection-related molecular mimicry, and ongoing immune system dysregulation can all contribute to this process. That’s why when someone has one autoimmune disease, physicians often watch for others. Understanding the bigger immune picture is key to modern autoimmune care.

03/13/2026

Next week will be conducting important research on the healing powers of sand, sun, and Vitamin Sea.

03/08/2026

Many people think of POTS as purely an autonomic nervous system disorder, but research suggests there may be more to the story. Some studies have found that patients with POTS—especially those with hypermobility or Ehlers-Danlos—can have reduced activity in the growth hormone–IGF-1 pathway. Growth hormone helps regulate muscle tone, vascular function, blood volume, and energy metabolism, all systems that can be impaired in POTS. This doesn’t mean low growth hormone causes POTS, and hormone therapy is not standard treatment. But it raises an interesting scientific question: could hormonal signaling play a role in why some patients struggle with severe fatigue, exercise intolerance, and poor muscle support? Understanding that connection could open new areas for research and treatment.